Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: A Safety Study of PF-08046045/SGN-35T in Adults With Advanced Cancers [Phase 1]
A Phase 1 safety study of PF-08046045/SGN-35T sponsored by Seagen has been terminated in adults with advanced lymphomas and Hodgkin disease.
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Physician's Choice Chemotherapy in PD-(L)1-refractory, Relapsed or Refractory Classical Hodgkin Lymphoma (MK-4280A-008) [Phase 2]
A Phase 2 trial comparing coformulated favezelimab/pembrolizumab to physician's choice chemotherapy in PD-(L)1-refractory classical Hodgkin …
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702) [NA]
A completed clinical trial update reporting long-term outcomes of alternative donor allogeneic transplantation across multiple hematologic d…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating cytokine-treated veto cells as an adoptive therapy after stem cell transplantation for various hematolog…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: STAY-STRONG Study of Exercise Training During Chemotherapy [NA]
The STAY-STRONG study evaluating exercise training during chemotherapy in lymphoma patients has completed, examining effects on body composi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma [Phase 2]
A Phase 2 clinical trial assessing a Yttrium-90 labeled anti-CD25 monoclonal antibody plus BEAM chemotherapy conditioning for patients with …
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Duvelisib in Combination With BMS-986345 in Lymphoid Malignancy [Phase 1]
A Phase 1 trial evaluating the combination of duvelisib with BMS-986345 in lymphoid malignancies, including non-Hodgkin lymphoma and Hodgkin…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: Real-life Efficacy and Toxicity of Brentuximab-Vedotin Associated With Bendamustine in Patients With Relapsed or Refractory Hodgkin Lymphoma (HL-R2-B2)
This clinical trial update reports real-world efficacy and toxicity data for the combination of Brentuximab vedotin with Bendamustine in pat…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer [Phase 1]
A Phase 1 trial evaluating natural killer cell therapy in combination with Interleukin-2 and the TGF-beta receptor I inhibitor vactosertib f…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Feasibility and Agreement of Remote Evaluation of Resting Heart Rate and Heart Rate Variability in Survivors of Hodgkin Lymphoma Treated With Chest Radiation (PILOT STUDY-SURVIVOR)
This completed pilot study assessed the feasibility of remotely evaluating resting heart rate and heart rate variability in survivors of Hod…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer [Phase 1, Phase 2]
This document details an ongoing Phase 1/2 clinical trial evaluating cobolimab in combination with dostarlimab in pediatric and young adult …
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine [Phase 1]
A Phase 1 clinical trial evaluating a haploidentical bone marrow transplant using post-transplant cyclophosphamide and bendamustine has comp…
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant [Phase 1]
Phase 1 study evaluating olaparib in combination with high-dose chemotherapy for relapsed or refractory lymphomas undergoing stem cell trans…
-
CLINICAL_TRIALS trial_result · 2025-10-30Clinical Trial Update: Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies [Phase 2]
Phase 2 trial evaluating reduced-intensity conditioning before allogeneic donor stem cell transplantation in patients with high-risk hematol…
-
CLINICAL_TRIALS trial_result · 2025-10-21Clinical Trial Update: Brentuximab Vedotin (SGN-35) in Transplant Eligible Patients With Relapsed or Refractory Hodgkin Lymphoma [Phase 2]
This clinical trial update reports Phase 2 results for Brentuximab vedotin (SGN-35) in transplant-eligible patients with relapsed or refract…
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers [Phase 2]
Phase II trial of XmAb20717 for advanced rare cancers has been suspended, with eligibility including microsatellite instability-high cancers…
-
CLINICAL_TRIALS trial_result · 2025-10-06Clinical Trial Update: Telehealth Exercise Intervention to Improve Cardiovascular Health in Lymphoma Survivors, TECHS Trial [NA]
Clinical trial update confirming completion of the TECHS trial, which tested a telehealth exercise program to improve cardiovascular health …
-
CLINICAL_TRIALS trial_result · 2025-10-06Clinical Trial Update: PET-Adapted First-Line Therapy With Nivolumab for Advanced Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial evaluating PET-adapted first-line therapy with nivolumab for advanced Hodgkin lymphoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: Doxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma [Phase 2]
A Phase 2 clinical trial update describes evaluating a five-drug combination (doxorubicin, vinblastine, dacarbazine, brentuximab vedotin, an…
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study
The CREST study update shows the cardiovascular reserve evaluation trial in transplant survivors is currently active but not recruiting, spo…
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: Phase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCL [Phase 2]
A Phase 2 study evaluating AFM13 in combination with AB-101 for relapsed or refractory Hodgkin lymphoma and CD30+ peripheral T-cell lymphoma…
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma [Phase 1]
Phase 1 trial of MT-601 in relapsed/refractory lymphoma shows safety and preliminary efficacy signals in both non-Hodgkin lymphoma and Hodgk…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study [Phase 2]
A single-arm Phase II trial in advanced Hodgkin lymphoma evaluating a very early PET-response-guided targeted therapy; results have been pos…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: FIL Study on ABVD DD-DI as Upfront Therapy in HL. [Phase 3]
Phase 3 clinical trial update on the FIL study evaluating ABVD DD-DI as upfront therapy for Hodgkin lymphoma. The trial status is completed.
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma [Phase 3]
A Phase 3 clinical trial compared two combination chemotherapy regimens in patients with stage III or stage IV Hodgkin lymphoma. The study s…